Showing results (471-480 of 763) with videos related to

Sort By:
Pageof 77
Kidney International|July 17, 2019
Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathyPaola Cassis, Monica Locatelli, Daniela Corna, et al.
American Journal of Physiology. Renal Physiology|November 9, 2012
Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effectsCarla Zoja, Daniela Corna, Valeria Nava, et al.
Stem Cells and Development|October 23, 2012
Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cellsSusanna Tomasoni, Lorena Longaretti, Cinzia Rota, et al.
The Journal of Pathology|January 9, 2022
Empagliflozin protects glomerular endothelial cell architecture in experimental diabetes through the VEGF-A/caveolin-1/PV-1 signaling pathwayMonica Locatelli, Carlamaria Zoja, Sara Conti, et al.
Clinical Transplants|April 12, 2007
The Bergamo Kidney Transplant ProgramNorberto Perico, Paolo Cravedi, Piero Ruggenenti, et al.
Ebiomedicine|July 28, 2018
Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug DiscoveryValentina Benedetti, Valerio Brizi, Patrizia Guida, et al.
Internal and Emergency Medicine|March 22, 2023
Post-COVID condition: dispensation of drugs and diagnostic tests as proxies of healthcare impactAlessandro Nobili, Barbara D'Avanzo, Mauro Tettamanti, et al.
Diabetes|September 28, 2002
Podocyte number in normotensive type 1 diabetic patients with albuminuriaKathryn E White, Rudolf W Bilous, Sally M Marshall, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 21, 2017
Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and NephropathyMisghina Weldegiorgis, Dick de Zeeuw, Liang Li, et al.
Diabetes Care|April 30, 2008
Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)Piero Ruggenenti, Ilian Iliev, Grazia Maria Costa, et al.
Pageof 77